Radiomic evaluation of treatment response in patients with glioblastoma: a pilot study

BACKGROUND: Pseudoprogression of glioblastoma multiforme (GBM) following treatment occurs in 33–64% of patients. Conventional MRI cannot distinguish between pseudoprogression (psPD) and true tumour progression (tPD). Radiomic features could be used as predictors of treatment response. Our aim is to...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Patel, Dr Markand, Zhan, Dr Jinfeng, Natarajan, Dr Kal, Flintham, Mr Robert, Davies, Dr Nigel, Sanghera, Dr Paul, Peet, Prof Andrew, Cruickshank, Prof Garth, Ughratdar, Mr Ismail, Duddalwar, Prof Vinay, Sawlani, Dr Vijay
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6168810/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy130.064
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak